Handelsbanken Fonder Ab Royalty Pharma PLC Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

A detailed history of Handelsbanken Fonder Ab transactions in Royalty Pharma PLC stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 721,327 shares of RPRX stock, worth $17.5 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

721,327

Previous 715,029 0.88%

Holding current value

$17.5 Million

Previous $18.9 Million 8.23%

% of portfolio

0.08%

Previous 0.08%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	BUY	$25.63 - $29.27 $161,417 - $184,342	6,298 Added 0.88%	721,327 $20.4 Million
Q2 2024 Aug 05, 2024	BUY	$26.26 - $29.9 $885,697 - $1.01 Million	33,728 Added 4.95%	715,029 $18.9 Million
Q1 2024 May 13, 2024	SELL	$27.46 - $31.33 $5.78 Million - $6.6 Million	-210,617 Reduced 23.61%	681,301 $20.7 Million
Q4 2023 Feb 01, 2024	SELL	$26.21 - $29.22 $1.04 Million - $1.16 Million	-39,718 Reduced 4.26%	891,918 $25.1 Million
Q3 2023 Oct 19, 2023	BUY	$26.26 - $31.38 $3.68 Million - $4.4 Million	140,300 Added 17.73%	931,636 $25.3 Million
Q2 2023 Aug 02, 2023	BUY	$29.6 - $36.56 $2.54 Million - $3.14 Million	85,802 Added 12.16%	791,336 $24.3 Million
Q1 2023 Apr 28, 2023	BUY	$32.77 - $39.4 $3.12 Million - $3.75 Million	95,081 Added 15.58%	705,534 $25.4 Million
Q4 2022 Feb 07, 2023	BUY	$39.17 - $44.04 $18.5 Million - $20.8 Million	471,553 Added 339.49%	610,453 $24.1 Million
Q3 2022 Oct 27, 2022	BUY	$39.88 - $44.65 $3.58 Million - $4.01 Million	89,700 Added 182.32%	138,900 $5.58 Million
Q2 2022 Aug 03, 2022	BUY	$37.53 - $44.22 $247,698 - $291,852	6,600 Added 15.49%	49,200 $2.07 Million
Q1 2022 May 11, 2022	BUY	$37.46 - $42.44 $329,648 - $373,472	8,800 Added 26.04%	42,600 $1.66 Million
Q3 2021 Nov 10, 2021	BUY	$36.14 - $42.24 $683,046 - $798,336	18,900 Added 126.85%	33,800 $1.22 Million
Q2 2021 Aug 03, 2021	BUY	$39.85 - $46.63 $593,765 - $694,787	14,900 New	14,900 $459,000
Q1 2021 Apr 29, 2021	SELL	$42.34 - $52.82 $344,816 - $430,166	-8,144 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$36.12 - $50.05 $294,161 - $407,607	8,144 New	8,144 $408,000

Others Institutions Holding RPRX

# of Institutions

413

Shares Held

283M

Call Options Held

578K

Put Options Held

47.5K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Royalty Pharma PLC Transaction History